Xiaoman Hou1, Yali Zhai2, Kevin Hu3, Chia-Jen Liu2, Aaron Udager2, Celeste L Pearce4, Eric R Fearon5, Kathleen R Cho6. 1. Departments of Pathology, University of Michigan Medical School, USA; Obstetrics and Gynecology Hospital, Fudan University, Shanghai, PR China. 2. Departments of Pathology, University of Michigan Medical School, USA. 3. Departments of Computational Medicine and Bioinformatics, University of Michigan Medical School, USA. 4. Departments of Epidemiology Department, University of Michigan School of Public Health, USA. 5. Departments of Pathology, University of Michigan Medical School, USA; Departments of Internal Medicine, University of Michigan Medical School, USA; Departments of Human Genetics, University of Michigan Medical School, USA. 6. Departments of Pathology, University of Michigan Medical School, USA; Departments of Internal Medicine, University of Michigan Medical School, USA. Electronic address: kathcho@umich.edu.
Abstract
OBJECTIVES: The "incessant ovulation" hypothesis links increased risk for tubo-ovarian high-grade serous carcinoma (HGSC) due to more ovulations and reduced risk conferred by pre-menopausal exposures like oral contraceptive use, multiparity, and breastfeeding. However, most women diagnosed with HGSC are postmenopausal, implying age is a major risk factor for HGSC. Our mouse model for HGSC, based on tamoxifen (TAM)-induced somatic inactivation of the Brca1, Trp53, Rb1, and Nf1 (BPRN) tumor suppressor genes in oviductal epithelium, recapitulates key genetic, histopathologic, and biological features of human HGSCs. We aimed to credential the model for future efforts to define biological and risk modification factors in HGSC pathogenesis. METHODS: BPRN mice were treated with TAM to induce tumors at defined ages and parity status. RESULTS: BPRN mice aged 9-months prior to tumor induction had markedly shorter survival than 6-8 week old mice induced to form tumors (median 46.5 weeks versus 61.5 weeks, log-rank test P = 0.0006). No significant differences in cancer phenotypes were observed between multiparous versus nulliparous BPRN mice. However, using a modified tumor model with one wild-type Nf1 allele (BPRNfl/+), nulliparous mice had more advanced tumors than multiparous mice (Mantel-Haenszel Chi-square test of association, P = 0.01). CONCLUSIONS: Our findings show aging is associated with significantly shortened survival post tumor induction in the BRPN model and multiparity delays development and/or progression of HGSC in certain genetic contexts. The findings support relevance of our mouse model to gain mechanistic insights into how known factors exert their protective effects and to test novel approaches for HGSC prevention.
OBJECTIVES: The "incessant ovulation" hypothesis links increased risk for tubo-ovarian high-grade serous carcinoma (HGSC) due to more ovulations and reduced risk conferred by pre-menopausal exposures like oral contraceptive use, multiparity, and breastfeeding. However, most women diagnosed with HGSC are postmenopausal, implying age is a major risk factor for HGSC. Our mouse model for HGSC, based on tamoxifen (TAM)-induced somatic inactivation of the Brca1, Trp53, Rb1, and Nf1 (BPRN) tumor suppressor genes in oviductal epithelium, recapitulates key genetic, histopathologic, and biological features of human HGSCs. We aimed to credential the model for future efforts to define biological and risk modification factors in HGSC pathogenesis. METHODS: BPRN mice were treated with TAM to induce tumors at defined ages and parity status. RESULTS: BPRN mice aged 9-months prior to tumor induction had markedly shorter survival than 6-8 week old mice induced to form tumors (median 46.5 weeks versus 61.5 weeks, log-rank test P = 0.0006). No significant differences in cancer phenotypes were observed between multiparous versus nulliparous BPRN mice. However, using a modified tumor model with one wild-type Nf1 allele (BPRNfl/+), nulliparous mice had more advanced tumors than multiparous mice (Mantel-Haenszel Chi-square test of association, P = 0.01). CONCLUSIONS: Our findings show aging is associated with significantly shortened survival post tumor induction in the BRPN model and multiparity delays development and/or progression of HGSC in certain genetic contexts. The findings support relevance of our mouse model to gain mechanistic insights into how known factors exert their protective effects and to test novel approaches for HGSC prevention.
Authors: Fabiola Medeiros; Michael G Muto; Yonghee Lee; Julia A Elvin; Michael J Callahan; Colleen Feltmate; Judy E Garber; Daniel W Cramer; Christopher P Crum Journal: Am J Surg Pathol Date: 2006-02 Impact factor: 6.394
Authors: J K Chan; R Urban; M K Cheung; K Osann; J Y Shin; A Husain; N N Teng; D S Kapp; J S Berek; G S Leiserowitz Journal: Br J Cancer Date: 2006-10-31 Impact factor: 7.640
Authors: S Intidhar Labidi-Galy; Eniko Papp; Dorothy Hallberg; Noushin Niknafs; Vilmos Adleff; Michael Noe; Rohit Bhattacharya; Marian Novak; Siân Jones; Jillian Phallen; Carolyn A Hruban; Michelle S Hirsch; Douglas I Lin; Lauren Schwartz; Cecile L Maire; Jean-Christophe Tille; Michaela Bowden; Ayse Ayhan; Laura D Wood; Robert B Scharpf; Robert Kurman; Tian-Li Wang; Ie-Ming Shih; Rachel Karchin; Ronny Drapkin; Victor E Velculescu Journal: Nat Commun Date: 2017-10-23 Impact factor: 14.919
Authors: Elizabeth A Loughran; Annemarie K Leonard; Tyvette S Hilliard; Ryan C Phan; Madeleine G Yemc; Elizabeth Harper; Emma Sheedy; Yuliya Klymenko; Marwa Asem; Yueying Liu; Jing Yang; Jeff Johnson; Laura Tarwater; Zonggao Shi; Matthew Leevy; Matthew J Ravosa; M Sharon Stack Journal: Neoplasia Date: 2018-05-10 Impact factor: 5.715
Authors: Lucia Tortorella; Giuseppe Vizzielli; Domenico Fusco; William C Cho; Roberto Bernabei; Giovanni Scambia; Giuseppe Colloca Journal: Aging Dis Date: 2017-10-01 Impact factor: 6.745
Authors: Jacob P Veenstra; Lucas Felipe Fernandes Bittencourt; Katherine M Aird Journal: Am J Physiol Cell Physiol Date: 2022-05-18 Impact factor: 5.282